⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GH News
Guardant Health, Inc. Common Stock
Guardant Health’s Shield Blood-based Screening Test for Colorectal Cancer Now Accessible Through National Test Ordering and Collection Network of Quest Diagnostics
businesswire.com
GH
Guardant Health Launches Coast-to-Coast Screening Tour, Bringing Shield Colon Cancer Blood Test to Over 100 Communities Across America
businesswire.com
GH
Actor and Cancer Advocate Patrick Dempsey Partners with Guardant Health to Raise Awareness about Colorectal Cancer Screening and Shield Blood Test, Sharing His Experience Getting Screened
businesswire.com
GH
Chicago Rallies to Fund Life-Saving Research and Patient Care Services at Susan G. Komen® 2026 Race for the Cure
businesswire.com
NTRA
GH
NVS
LLY
Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
businesswire.com
GH
Surgical Simulation Market worth $349.4 million by 2030 | MarketsandMarkets™
prnewswire.com
ISRG
OSUR
GH
MD
SIM
Personalized Medicine Biomarkers Market Research Report 2026: Next-Generation Sequencing Breakthroughs and High-Throughput Mutation Analysis Drives Growth - Trends, Opportunities and Forecast to 2031
globenewswire.com
GH
Form 8-K
sec.gov
GH
Guardant Health Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Outlook
businesswire.com
GH
Guardant Health Launches Community Colorectal Cancer Screening Grant Program in Recognition of CRC Awareness Month, Applications Now Open
prnewswire.com
GH